LEPTOSPIRA SP - ANVISA Registration 10259610242

Access comprehensive regulatory information for LEPTOSPIRA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10259610242 and manufactured by manufacturer not specified. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until Dec 10, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including INSTITUT VIRION\SERION GMBH, HANGZHOU ALLTEST BIOTECH CO. LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10259610242
2 Related Devices
Registration Details
ANVISA Registration Number: 10259610242
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Leptospira Virclia IgM Monotest
Risk Class III

Registration Details

10259610242

25351155493202360

68814961000173

Company Information

Dates and Status

Mar 27, 2023

10/12/2028

09/18/2025 19:00:01

Leptospira Virclia IgM Monotest
Risk Class III

Registration Details

10259610242

25351155493202360

68814961000173

Company Information

Spain
PT: ESPANHA

Dates and Status

Mar 27, 2023

10/12/2028

09/18/2025 19:00:01